- Home /
- Live Rates /
- BNTX

<% signal.analyst %>
<% signal.analyst %>
Last Updated: Apr 01, 2026 11:35:07 AM (GMT)
BNTX: The current market price is 88.79, remaining unchanged.
Support and Resistance Levels Current levels indicate support at 88.79 and resistance at 88.79, with a pivot point also at 88.79.
Indicators The RSI currently stands at 78.58, showing a strong bullish signal but has recently dropped from a high of 100. The ATR is at 0.16064, indicating low volatility. The Parabolic SAR, currently at 86.29406, shows an upward movement. The MACD shows a histogram of -0.09853, suggesting a potential bearish divergence.
Market Sentiment Considering the price is above the pivot of 88.79, and strong indicators suggest a bullish scenario.
BNTX Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (BNTX) BioNTech SE
Company Background
BioNTech SE, a German biotechnology company, is a pioneer in the development of personalized immunotherapies for the treatment of cancer and infectious diseases. Founded in 2008, BioNTech has rapidly advanced its innovative mRNA technology platform, which garnered international attention during the COVID-19 pandemic with the development of its highly effective vaccine in collaboration with Pfizer. Headquartered in Mainz, Germany, the company focuses on creating transformative therapies that harness the body’s immune system to fight diseases more effectively.Market Position
As a leader in the biotechnology sector, BioNTech is positioned at the forefront of the global race to develop targeted therapies and vaccines. The company’s pioneering work in mRNA technology has established it as a key player in the biotech industry. BioNTech’s diverse product pipeline includes therapies for various cancers and infectious diseases, with several candidates in late-stage clinical trials. The company's market capitalization and strong partnerships with pharmaceutical leaders underscore its significant role in advancing medical science and improving patient outcomes.Key Financial Highlights
BioNTech’s financial performance has witnessed remarkable growth due to the unprecedented demand for its COVID-19 vaccine. As of the most recent fiscal reports, the company has generated substantial revenues, allowing for increased investments in research and development. This financial strength enables BioNTech to explore new opportunities in biotechnology, including its promising pipeline of personalized cancer therapies and next-generation vaccines. Analysts anticipate continued growth, driven by ongoing innovation and strategic collaborations, positioning BioNTech favorably within the competitive landscape of biotechnology.Industry Highlights
The biotechnology industry is experiencing robust growth, propelled by advancements in genetic research and technology. BioNTech is at the cutting edge of this evolution, leveraging its mRNA expertise not only for vaccines but also for therapeutic applications. With a strong focus on personalized medicine and immunotherapy, BioNTech is well-equipped to meet the challenges of modern healthcare. The company's ongoing commitment to scientific excellence and collaborative partnerships positions it as a key contributor to the future of medicine, enhancing its long-term prospects as a prominent player in the biotechnology market.Related Stocks
Indicator Alert
Warning: Several indicator values are missing for this timeframe. Please choose another timeframe to continue.
Sidebar rates
- <% signal.pair %>
